# Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy

> **NCT07637942** · — · NOT_YET_RECRUITING · sponsor: **International Maternal Pediatric Adolescent AIDS Clinical Trials Group** · enrollment: 40 (estimated)

## Conditions studied

- HIV -1 Infection

## Interventions

- **DRUG:** Every 4-week long-acting injectable cabotegravir and rilpivirine

## Key facts

- **NCT ID:** NCT07637942
- **Lead sponsor:** International Maternal Pediatric Adolescent AIDS Clinical Trials Group
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10-15
- **Primary completion:** 2028-03-22
- **Final completion:** 2028-03-22
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-08-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07637942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07637942, "Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07637942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*